SIRT1 Expression Is Associated With Cell Proliferation in Angiosarcoma

Anticancer Res. 2019 Mar;39(3):1143-1150. doi: 10.21873/anticanres.13223.

Abstract

Background/aim: Angiosarcoma is a rare and aggressive soft tissue sarcoma with poor prognosis. Chemotherapy and radiotherapy do not improve the prognosis. SIRT1, a class III histone deacetylase, is up-regulated in many malignant tumours. This study aimed at exploring the role of SIRTl in angiosarcoma.

Materials and methods: The effect of suppressing SIRT1 expression with siRNA on the proliferation and invasion ability of ISO-HAS-B angiosarcoma cells was investigated. Additionally, SIRT1 expression in tissues from surgical specimens was immunohistochemically evaluated and compared to that from benign tumours.

Results: Suppression of SIRT1 expression by siRNA resulted in the down-regulation of cell growth, proliferation, migration, and invasion. An immunohistochemical analysis disclosed that SIRT1 expression in angiosarcoma was stronger than that in haemangioma.

Conclusion: SIRT1 may be involved in the invasive proliferation and malignant transformation of angiosarcoma, and may be considered a future target for angiosarcoma therapy.

Keywords: SIRT1; angiosarcoma; cell proliferation.

MeSH terms

  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Hemangiosarcoma / metabolism*
  • Hemangiosarcoma / pathology
  • Humans
  • RNA, Small Interfering / administration & dosage
  • Sirtuin 1 / genetics
  • Sirtuin 1 / metabolism*
  • Wound Healing

Substances

  • RNA, Small Interfering
  • SIRT1 protein, human
  • Sirtuin 1